Immunoadjuvant adjunctive IFN-γ therapy, along with IL-7 and anti-PD1/PD-L1, could be beneficial for patients with sepsis, as it has proven impacts on enhancing CD4+ and CD8+ T cell functions. Here, CD8A is linked to Sepsis.